Larsimont D - Search Results

1

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.

Toussaint J, Sieuwerts AM, Haibe-Kains B, Desmedt C, Rouas G, Harris AL, Larsimont D, Piccart M, Foekens JA, Durbecq V, Sotiriou C. Toussaint J, et al. Among authors: larsimont d. BMC Genomics. 2009 Sep 10;10:424. doi: 10.1186/1471-2164-10-424. BMC Genomics. 2009. PMID: 19744330 Free PMC article.

2

Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome.

Lespagnard L, Gancberg D, Rouas G, Leclercq G, de Saint-Aubain Somerhausen N, Di Leo A, Piccart M, Verhest A, Larsimont D. Lespagnard L, et al. Among authors: larsimont d. Int J Cancer. 1999 Jun 21;84(3):309-14. doi: 10.1002/(sici)1097-0215(19990621)84:3<309::aid-ijc19>3.0.co;2-3. Int J Cancer. 1999. PMID: 10371352 Free article.

3

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.

Di Leo A, Crown J, Nogaret JM, Duffy K, Bartholomeus S, Dolci S, Rowan S, O'Higgins N, Paesmans M, Larsimont D, Riva A, Piccart MJ. Di Leo A, et al. Among authors: larsimont d. Ann Oncol. 2000 Feb;11(2):169-75. doi: 10.1023/a:1008345432342. Ann Oncol. 2000. PMID: 10761751 Free article. Clinical Trial.

4

Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases.

Gancberg D, Lespagnard L, Rouas G, Paesmans M, Piccart M, Di Leo A, Nogaret JM, Hertens D, Verhest A, Larsimont D. Gancberg D, et al. Among authors: larsimont d. Am J Clin Pathol. 2000 May;113(5):675-82. doi: 10.1309/0F58-0GRX-FK4R-A6VA. Am J Clin Pathol. 2000. PMID: 10800400

5

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J. Tanner M, et al. Among authors: larsimont d. Am J Pathol. 2000 Nov;157(5):1467-72. doi: 10.1016/S0002-9440(10)64785-2. Am J Pathol. 2000. PMID: 11073807 Free PMC article.

6

Trisomy 6 in Merkel cell carcinoma: a recurrent chromosomal aberration.

Gancberg D, Feoli F, Hamels J, de Saint-Aubain N, André J, Rouas G, Verhest A, Larsimont D. Gancberg D, et al. Among authors: larsimont d. Histopathology. 2000 Nov;37(5):445-51. doi: 10.1046/j.1365-2559.2000.01011.x. Histopathology. 2000. PMID: 11119126

7

Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases.

Sotiriou C, Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ. Sotiriou C, et al. Among authors: larsimont d. Cancer Lett. 2001 Aug 10;169(1):87-95. doi: 10.1016/s0304-3835(01)00524-9. Cancer Lett. 2001. PMID: 11410329

8

Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes.

Cardoso F, Di Leo A, Larsimont D, Gancberg D, Rouas G, Dolci S, Ferreira F, Paesmans M, Piccart M. Cardoso F, et al. Among authors: larsimont d. Ann Oncol. 2001 May;12(5):615-20. doi: 10.1023/a:1011182524684. Ann Oncol. 2001. PMID: 11432618 Free article.

9

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide.

Di Leo A, Larsimont D, Gancberg D, Jarvinen T, Beauduin M, Vindevoghel A, Michel J, Focan CH, Ries F, Gobert PH, Closon-Dejardin MT, Dolci S, Rouas G, Paesmans M, Lobelle JP, Isola J, Piccart MJ. Di Leo A, et al. Among authors: larsimont d. Ann Oncol. 2001 Aug;12(8):1081-9. doi: 10.1023/a:1011669223035. Ann Oncol. 2001. PMID: 11583189 Free article. Clinical Trial.

10

The predictive value of HER2 in breast cancer.

Piccart M, Lohrisch C, Di Leo A, Larsimont D. Piccart M, et al. Among authors: larsimont d. Oncology. 2001;61 Suppl 2:73-82. doi: 10.1159/000055405. Oncology. 2001. PMID: 11694791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page